S SONORANT THERAPEUTICS

Serial Number 88464881
Registration 6078030
700

Registration Progress

Application Filed
Jun 7, 2019
Under Examination
Approved for Publication
Mar 31, 2020
Published for Opposition
Mar 31, 2020
Registered
Jun 16, 2020

Attorney Assistance

Important Deadline Approaching

Section 8 (6-Year) Declaration Due (Based on registration date 2020-06-16)
Due: June 16, 2026 (344 days remaining)

Missing this deadline could result in abandonment or cancellation of your trademark.

Basic Information

Serial Number
88464881
Registration Number
6078030
Deadline
June 16, 2026
Description
5 Year - Section 8 and 15 Renewal
Filing Date
June 7, 2019
Registration Date
June 16, 2020
Published for Opposition
March 31, 2020
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
Jun 16, 2020
Registration
Registered
Classes
005 010 040 041
+1 more

Rights Holder

Mallinckrodt Pharmaceuticals Ireland Limited

99
Address
College Business & Technology Park
Cruiserath Road, Blanchardstown
Dublin 15 D15TX2V
IE

Ownership History

Mallinckrodt Pharmaceuticals Ireland Limited

Original Applicant
99
Dublin 15 IE

Mallinckrodt Pharmaceuticals Ireland Limited

Owner at Publication
99
Dublin 15 IE

Mallinckrodt Pharmaceuticals Ireland Limited

Original Registrant
99
Dublin 15 IE

Legal Representation

Attorney
Jeannine A Rittenhouse

USPTO Deadlines

Next Renewal Deadline
344 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2020-06-16)
Due Date
June 16, 2026
Grace Period Ends
December 16, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

23 events
Date Code Type Description
Jun 16, 2025 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Nov 22, 2023 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Oct 12, 2022 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Jul 13, 2022 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Jun 16, 2020 R.PR A REGISTERED-PRINCIPAL REGISTER
Jun 10, 2020 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Mar 31, 2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 31, 2020 PUBO A PUBLISHED FOR OPPOSITION
Mar 11, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 27, 2020 CHPB I POST PUBLICATION AMENDMENT - ENTERED
Feb 26, 2020 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 26, 2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 26, 2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 20, 2020 ALIE A ASSIGNED TO LIE
Feb 13, 2020 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 13, 2020 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 26, 2019 CNRT R NON-FINAL ACTION WRITTEN
Aug 26, 2019 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 26, 2019 GNRT F NON-FINAL ACTION E-MAILED
Aug 24, 2019 DOCK D ASSIGNED TO EXAMINER
Jun 22, 2019 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED
Jun 21, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 11, 2019 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of neurological diseases and disorders, nephrotic diseases, endocrine disorders, rheumatic disorders, collagen diseases, dermatologic diseases and disorders, allergic states, ophthalmic diseases, respiratory diseases, hematologic disorders, neoplastic diseases, edematous state, gastrointestinal diseases, hepatic diseases and disorders, biliary diseases and disorders, renal disorders, cardiovascular and lipid-related diseases and disorders, inflammatory and autoimmune diseases and disorders; intravenous analgesics and antipyretics; medical gases for inhalation; bioengineered tissues for surgical implantation
Class 010
Medical apparatus and instruments for use in connection with the administration of gases to patients for medical and therapeutic purposes and accessories and parts thereof, namely, medical and therapeutic gas delivery systems comprised primarily of gas cylinders, valves, regulators, flow meters, delivery hoses and apparatus and instruments for setting, measuring and regulating the mixture of medical and therapeutic gases delivered to patients; Therapeutic medical device and accessories and parts thereof for extracting blood from the body, separating blood, treating it extracorporally, and returning it to the body used for extracorporeal photopheresis, extracorporeal photo immune therapy, extracorporeal photo chemotherapy, and cellular therapies; injection devices incorporating prefilled syringes containing injectable pharmaceuticals for manual injection
Class 040
Custom manufacturing of pharmaceuticals and active pharmaceutical ingredients
Class 041
educational services, namely, training in the fields of pharmaceutical dosing and training in the use and operation of medical devices used to administer nitric oxide to a patient and medical devices used to administer extracorporeal photopheresis to a patient; educational services, namely, providing classes, seminars, and workshops in the fields of pharmaceuticals and medical devices
Class 042
Scientific research services for medical purposes

Additional Information

Design Mark
The mark consists of a design of a stylized "S" in purple on the left, with a design of 5 vertical lines that vary in length across the middle of the "S", with the tallest in the middle and the shortest on the outside, in blue and purple fading from top to bottom. The stylized wording "SONORANT THERAPEUTICS" is stacked vertically on the right, in purple.
Color Claim
The color(s) blue and purple is/are claimed as a feature of the mark.

Classification

International Classes
005 010 040 041 042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"THERAPEUTICS"